SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-029339
Filing Date
2022-08-12
Accepted
2022-08-12 17:06:46
Documents
67
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q elox-10q_20220630.htm   iXBRL 10-Q 2114271
2 EX-31.1 elox-ex311_9.htm EX-31.1 8707
3 EX-31.2 elox-ex312_7.htm EX-31.2 9233
4 EX-32.1 elox-ex321_8.htm EX-32.1 6960
5 EX-32.2 elox-ex322_6.htm EX-32.2 6859
  Complete submission text file 0001564590-22-029339.txt   6748664

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA elox-20220630.xsd EX-101.SCH 49040
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE elox-20220630_cal.xml EX-101.CAL 53390
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE elox-20220630_def.xml EX-101.DEF 117155
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE elox-20220630_lab.xml EX-101.LAB 351475
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE elox-20220630_pre.xml EX-101.PRE 266153
61 EXTRACTED XBRL INSTANCE DOCUMENT elox-10q_20220630_htm.xml XML 1071167
Mailing Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472 781-577-5300
Eloxx Pharmaceuticals, Inc. (Filer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31326 | Film No.: 221161122
SIC: 2836 Biological Products, (No Diagnostic Substances)